Nanoscience of `Self' 2.0: blocking CD47 recognition by phagocytes in blood & solid tumor clearance Nanoparticle coatings of PEG or other polymers have been a standard approach for prolonging circulation in order to maximize delivery to disease sites. However, particles always develop a corona of serum proteins including IgG, IgM, etc. that signal `eat me' to macrophages in the spleen, liver, and even tumors. Specific antibodies can also develop, including anti-PEG. CD47 is a protein on all of our cells that signals `Self' to macrophages and overrides `eat me' factors on the surface of our cells. We showed human-CD47 inhibits phagocytosis of IgG-coated particles and RBCs that signal at a `phagocytic synapse' through SIRPa [Tsai & Discher J Cell Biol 2008]. `Self'-nanobeads show delayed clearance from the circulation and improved delivery to tumor xenografts in NOD/SCID/? (NSG) mice with a human-compatible SIRPa [Rodriguez Science 2013]. Blocking SIRPa with antibody also eliminated `Self' signaling. Our first R01 allowed us ? among other accomplishments ? to improve gene delivery to the same xenograft model with novel nano-characterized CD47-Lentivirus [Sosale Mol Ther-MCD 2016], and we developed a safe and effective therapy with SIRPa-inhibited macrophages [Alvey Curr Biol 2017]. We propose to advance the safety and efficacy of this eng'd macrophage approach using diverse nano approaches. Phase-I clinical trials in cancer patients are already using anti-(humanCD47) for blockade because CD47 is expressed on cancer cells as on all cells. Initial reports from the anti-(humanCD47) trials are showing anemia but no efficacy. Our mouse models injected with anti-(mouseCD47) likewise show no efficacy against cancer and show anemia as well as anti-RBC IgG ? and so the model is appropriate for our new approach. Our overall hypothesis is that CD47 opposes engulfment and thereby inhibits acquired immunity. Our goal is to show an eng'd macrophage therapy can be injected systemically and prove safe (no autoimmune anemia) and sufficiently effective that mice cured of tumors acquire immunity to further injection of cancer cells. Diverse nano-tools will help test the hypothesis and achieve our goal, including nanoparticle tests of acquired immunity, nanoparticle tracking of eng'd macrophages, and new nano-Self blockade approaches.

Public Health Relevance

Project Relevance to Public Health SIGNIFICANCE: Phase-I clinical trials in cancer patients are currently using antibodies that block a ubiquitously expressed membrane protein called CD47 which binds to a counter-receptor SIRPa on macrophages to signal ?Don't Eat Me!?. Initial reports from the trials show no efficacy and instead show anemia and other systemic side effects that raise concerns about autoimmunity. We will use an array of nanoparticles and nano-methods to clarify the processes in clinically relevant models and to ultimately develop a translatable approach of blocking CD47-SIRPa for safe and effective regression of tumors.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Nanotechnology Study Section (NANO)
Program Officer
Qasba, Pankaj
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Engineering (All Types)
Biomed Engr/Col Engr/Engr Sta
United States
Zip Code
Nair, Praful R; Alvey, Cory; Jin, Xiaoling et al. (2018) Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival. Bioconjug Chem 29:914-927
Smith, Lucas R; Cho, Sangkyun; Discher, Dennis E (2018) Stem Cell Differentiation is Regulated by Extracellular Matrix Mechanics. Physiology (Bethesda) 33:16-25
Steinkühler, Jan; Ró?ycki, Bartosz; Alvey, Cory et al. (2018) Membrane fluctuations and acidosis regulate cooperative binding of 'marker of self' protein CD47 with the macrophage checkpoint receptor SIRP?. J Cell Sci 132:
Holle, Andrew W; Young, Jennifer L; Van Vliet, Krystyn J et al. (2018) Cell-Extracellular Matrix Mechanobiology: Forceful Tools and Emerging Needs for Basic and Translational Research. Nano Lett 18:1-8
Chakraborty, Kaushik; Vijayan, Kandaswamy; Brown, Andre E X et al. (2018) Glassy worm-like micelles in solvent and shear mediated shape transitions. Soft Matter 14:4194-4203
Harding, Shane M; Benci, Joseph L; Irianto, Jerome et al. (2017) Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548:466-470
Ivanovska, Irena L; Swift, Joe; Spinler, Kyle et al. (2017) Cross-linked matrix rigidity and soluble retinoids synergize in nuclear lamina regulation of stem cell differentiation. Mol Biol Cell 28:2010-2022
Raab, Matthew; Discher, Dennis E (2017) Matrix rigidity regulates microtubule network polarization in migration. Cytoskeleton (Hoboken) 74:114-124
Mahmud, Abdullah; Harada, Takamasa; Rajagopal, Karthikan et al. (2017) Spray stability of self-assembled filaments for delivery. J Control Release 263:162-171
Buxboim, Amnon; Irianto, Jerome; Swift, Joe et al. (2017) Coordinated increase of nuclear tension and lamin-A with matrix stiffness outcompetes lamin-B receptor that favors soft tissue phenotypes. Mol Biol Cell 28:3333-3348

Showing the most recent 10 out of 34 publications